Obesity Mediates Response to Antiarrhythmic Drugs in A-Fib
MONDAY, Dec. 2, 2019 -- Obesity may cause a differential response to antiarrhythmic drugs (AADs) used to suppress atrial fibrillation (AF), according to a study published online Nov. 27 in JAMA Cardiology.
Aylin Ornelas-Loredo, from the University...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Atrial Fibrillation | Cardiology | Eating Disorders & Weight Management | Heart | Obesity | Pharmaceuticals | Study